120 related articles for article (PubMed ID: 11786275)
21. Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans.
Ananthan S; Kezar HS; Saini SK; Khare NK; Davis P; Dersch CM; Porreca F; Rothman RB
Bioorg Med Chem Lett; 2003 Feb; 13(3):529-32. PubMed ID: 12565965
[TBL] [Abstract][Full Text] [Related]
22. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
[TBL] [Abstract][Full Text] [Related]
23. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
Birch PJ; Rogers H; Hayes AG; Hayward NJ; Tyers MB; Scopes DI; Naylor A; Judd DB
Br J Pharmacol; 1991 Jul; 103(3):1819-23. PubMed ID: 1657267
[TBL] [Abstract][Full Text] [Related]
25. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris-ciliary bodies: role of phosphodiesterase and protein kinase C.
Dortch-Carnes J; Potter DE
J Pharmacol Exp Ther; 2002 May; 301(2):599-604. PubMed ID: 11961062
[TBL] [Abstract][Full Text] [Related]
27. A novel, potent, oral active and safe antinociceptive pyrazole targeting kappa opioid receptors.
Trevisan G; Rossato MF; Walker CI; Oliveira SM; Rosa F; Tonello R; Silva CR; Machado P; Boligon AA; Martins MA; Zanatta N; Bonacorso HG; Athayde ML; Rubin MA; Calixto JB; Ferreira J
Neuropharmacology; 2013 Oct; 73():261-73. PubMed ID: 23791558
[TBL] [Abstract][Full Text] [Related]
28. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
29. Selective kappa-opioid antagonists related to naltrindole. Effect of side-chain spacer in the 5'-amidinoalkyl series.
Jales AR; Husbands SM; Lewis JW
Bioorg Med Chem Lett; 2000 Oct; 10(20):2259-61. PubMed ID: 11055333
[TBL] [Abstract][Full Text] [Related]
30. Modulation of neurotransmitter release by opioid mu- and kappa-receptors from adrenergic terminals in the myenteric plexus of the guinea-pig colon: effect of alpha 2-autoreceptor blockade.
Cosentino M; Marino F; Bombelli R; Ferrari M; Rasini E; Giaroni C; Lecchini S; Frigo G
Neurosci Lett; 1997 Jan; 222(2):75-8. PubMed ID: 9111732
[TBL] [Abstract][Full Text] [Related]
31. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
Skoubis PD; Matthes HW; Walwyn WM; Kieffer BL; Maidment NT
Neuroscience; 2001; 106(4):757-63. PubMed ID: 11682161
[TBL] [Abstract][Full Text] [Related]
32. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
33. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
Bart G; Schluger JH; Borg L; Ho A; Bidlack JM; Kreek MJ
Neuropsychopharmacology; 2005 Dec; 30(12):2254-62. PubMed ID: 15988468
[TBL] [Abstract][Full Text] [Related]
34. Kappa opioid receptor binding in major depression: A pilot study.
Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
[TBL] [Abstract][Full Text] [Related]
35. Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.
Patkar KA; Wu J; Ganno ML; Singh HD; Ross NC; Rasakham K; Toll L; McLaughlin JP
J Pharmacol Exp Ther; 2013 Sep; 346(3):545-54. PubMed ID: 23853171
[TBL] [Abstract][Full Text] [Related]
36. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers.
Furness MS; Zhang X; Coop A; Jacobson AE; Rothman RB; Dersch CM; Xu H; Porreca F; Rice KC
J Med Chem; 2000 Aug; 43(16):3193-6. PubMed ID: 10956228
[TBL] [Abstract][Full Text] [Related]
37. The in vitro pharmacological characterization of naloxone benzoylhydrazone.
Berzetei-Gurske IP; White A; Polgar W; DeCosta BR; Pasternak GW; Toll L
Eur J Pharmacol; 1995 Apr; 277(2-3):257-63. PubMed ID: 7493617
[TBL] [Abstract][Full Text] [Related]
38. Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia.
McIntosh M; Kane K; Parratt J
Eur J Pharmacol; 1992 Jan; 210(1):37-44. PubMed ID: 1318203
[TBL] [Abstract][Full Text] [Related]
39. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
40. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels.
Watkins LR; Wiertelak EP; Maier SF
Brain Res; 1992 Jun; 582(1):1-9. PubMed ID: 1354010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
